Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 3,532 | -5,545 | N/A | N/A |
| Depreciation Amortization | 308 | 580 | N/A | N/A |
| Accounts receivable | -1,455 | 268 | N/A | N/A |
| Other Working Capital | 9,268 | -1,247 | N/A | N/A |
| Other Operating Activity | 2,950 | 148 | 0 | 0 |
| Operating Cash Flow | $14,603 | $-5,796 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -140 | -37 | N/A | N/A |
| Investing Cash Flow | $-140 | $-37 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | N/A | 1,960 | N/A | N/A |
| Debt Issued | 5,000 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 4 | N/A | N/A |
| Other Financing Activity | -85 | 0 | 0 | 0 |
| Financing Cash Flow | $4,915 | $1,964 | $N/A | $N/A |
| Beginning Cash Position | 2,810 | 6,679 | N/A | N/A |
| End Cash Position | 22,188 | 2,810 | N/A | N/A |
| Net Cash Flow | $19,378 | $-3,869 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 14,603 | -5,796 | N/A | N/A |
| Capital Expenditure | -145 | -37 | N/A | N/A |
| Free Cash Flow | 14,458 | -5,833 | 0 | 0 |